Literature DB >> 11716504

The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells.

F Barry1, R Boynton, M Murphy, S Haynesworth, J Zaia.   

Abstract

Mesenchymal stem cells (MSCs) are pluripotent cells in the bone marrow that have the capacity to differentiate along a number of connective tissue lineages, including cartilage, bone, adipose tissue, and stroma. The SH-3 and SH-4 monoclonal antibodies recognize epitopes present on the surface of human MSCs. This study describes the isolation and characterization of the antigen that is recognized by these antibodies. A protein of molecular weight approximately 67 kDa was immunoprecipitated from a solubilized membrane preparation of human MSCs using the SH-3 antibody. Analysis of peptides derived from this protein by mass spectrometry and sequencing identified it as CD73 (ecto-5'-nucleotidase). The SH-4 antibody was also shown to react with purified bovine CD73 by immunoblotting, but the SH-3 antibody failed to react with the bovine protein. These results indicate that both SH-3 and SH-4 epitopes are present on CD73, but they are distinct. CD73, present in lymphoid tissue, plays a role in the activation of B-lymphocytes and in signal transduction in the hematopoietic compartment of bone marrow. The role that CD73 may play in bone marrow stromal interactions and in the differentiation of MSCs is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716504     DOI: 10.1006/bbrc.2001.6013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  54 in total

Review 1.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Easily-handled method to isolate mesenchymal stem cells from coagulated human bone marrow samples.

Authors:  Heng-Xiang Wang; Zhi-Yong Li; Zhi-Kun Guo; Zi-Kuan Guo
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

3.  Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.

Authors:  Young-sup Yoon; Andrea Wecker; Lindsay Heyd; Jong-Seon Park; Tengiz Tkebuchava; Kengo Kusano; Allison Hanley; Heather Scadova; Gangjian Qin; Dong-Hyun Cha; Kirby L Johnson; Ryuichi Aikawa; Takayuki Asahara; Douglas W Losordo
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Isolation of renal progenitor cells from adult human kidney.

Authors:  Benedetta Bussolati; Stefania Bruno; Cristina Grange; Stefano Buttiglieri; Maria Chiara Deregibus; Dario Cantino; Giovanni Camussi
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

5.  Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs.

Authors:  Caridad Martinez; Ted J Hofmann; Roberta Marino; Massimo Dominici; Edwin M Horwitz
Journal:  Blood       Date:  2007-01-30       Impact factor: 22.113

Review 6.  Mesenchymal stromal cells.

Authors:  Armand Keating
Journal:  Curr Opin Hematol       Date:  2006-11       Impact factor: 3.284

Review 7.  New era of cell-based orthopedic therapies.

Authors:  Arnold I Caplan
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

8.  Clonal growth, phenotype, and differentiation potential of mesenchymal stromal cells derived from the rat fetal bone.

Authors:  O V Payushina; N N Butorina; O N Sheveleva; S S Bukhinnik; E I Domaratskaya
Journal:  Dokl Biol Sci       Date:  2014-01-03

9.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

Review 10.  Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Jican Dai; Tom F Lue
Journal:  Histol Histopathol       Date:  2013-04-16       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.